OpenLobby.EU

SERB France

SERB

SERB began in the 1950s in France as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research).

Lobbying Activity

Meeting with Boriša Falatar (Cabinet of Commissioner Hadja Lahbib)

3 Jul 2025 · EU CBRN preparedness strategy and the role of the pharmaceutical industry

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Strategy to support medical countermeasures against public health threats

9 May 2025

Response to Communication on the EU Stockpiling Strategy

9 May 2025